US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 2.4600
  • -0.1600-6.11%
Close Aug 9 16:00 ET
  • 2.6900
  • +0.2300+9.35%
Post 20:01 ET
3.24MMarket Cap-131P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
66.46%2.88M
40.65%3.2M
-16.88%8.04M
29.69%2.22M
-25.92%1.81M
-36.55%1.73M
-18.25%2.28M
23.13%9.67M
-32.95%1.71M
42.86%2.45M
Selling and administrative expenses
-2.11%874.64K
47.72%1.6M
-1.28%3.97M
31.89%1.08M
1.82%909K
-20.08%893.48K
-8.84%1.09M
-8.51%4.02M
-42.94%822.33K
-2.16%892.78K
-General and administrative expense
-2.11%874.64K
47.72%1.6M
-1.28%3.97M
31.89%1.08M
1.82%909K
-20.08%893.48K
-8.84%1.09M
-8.51%4.02M
-42.94%822.33K
-2.16%892.78K
Research and development costs
139.48%2.01M
34.22%1.6M
-27.98%4.07M
27.65%1.14M
-41.87%902.98K
-47.97%838.93K
-25.27%1.19M
63.36%5.65M
-20.01%889.36K
94.22%1.55M
Operating profit
-66.46%-2.88M
-40.65%-3.2M
16.88%-8.04M
-29.69%-2.22M
25.92%-1.81M
36.55%-1.73M
18.25%-2.28M
-23.13%-9.67M
32.95%-1.71M
-42.86%-2.45M
Net non-operating interest income expense
75.96%54.64K
84.60%69.3K
288.87%247.22K
104.00%85.86K
331.76%92.77K
31.05K
37.54K
239.37%63.57K
42.09K
3,400.46%21.49K
Non-operating interest income
75.96%54.64K
84.60%69.3K
288.87%247.22K
104.00%85.86K
331.76%92.77K
--31.05K
--37.54K
--63.57K
--42.09K
--21.49K
Other net income (expense)
Income before tax
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
Income tax
Net income
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
Net income continuous Operations
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
Minority interest income
Net income attributable to the parent company
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
8.16%-9.61M
34.60%-1.67M
43.29%-2.42M
Basic earnings per share
55.67%-4.18
79.30%-7.05
80.82%-40.05
72.30%-8.1432
82.91%-8.1
83.88%-9.43
57.57%-34.05
64.20%-208.8
60.04%-29.4
77.03%-47.4
Diluted earnings per share
55.67%-4.18
79.30%-7.05
80.82%-40.05
72.30%-8.1432
82.91%-8.1
83.88%-9.43
57.57%-34.05
64.20%-208.8
60.04%-29.4
77.03%-47.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 66.46%2.88M40.65%3.2M-16.88%8.04M29.69%2.22M-25.92%1.81M-36.55%1.73M-18.25%2.28M23.13%9.67M-32.95%1.71M42.86%2.45M
Selling and administrative expenses -2.11%874.64K47.72%1.6M-1.28%3.97M31.89%1.08M1.82%909K-20.08%893.48K-8.84%1.09M-8.51%4.02M-42.94%822.33K-2.16%892.78K
-General and administrative expense -2.11%874.64K47.72%1.6M-1.28%3.97M31.89%1.08M1.82%909K-20.08%893.48K-8.84%1.09M-8.51%4.02M-42.94%822.33K-2.16%892.78K
Research and development costs 139.48%2.01M34.22%1.6M-27.98%4.07M27.65%1.14M-41.87%902.98K-47.97%838.93K-25.27%1.19M63.36%5.65M-20.01%889.36K94.22%1.55M
Operating profit -66.46%-2.88M-40.65%-3.2M16.88%-8.04M-29.69%-2.22M25.92%-1.81M36.55%-1.73M18.25%-2.28M-23.13%-9.67M32.95%-1.71M-42.86%-2.45M
Net non-operating interest income expense 75.96%54.64K84.60%69.3K288.87%247.22K104.00%85.86K331.76%92.77K31.05K37.54K239.37%63.57K42.09K3,400.46%21.49K
Non-operating interest income 75.96%54.64K84.60%69.3K288.87%247.22K104.00%85.86K331.76%92.77K--31.05K--37.54K--63.57K--42.09K--21.49K
Other net income (expense)
Income before tax -66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M
Income tax
Net income -66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M
Net income continuous Operations -66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M
Minority interest income
Net income attributable to the parent company -66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M8.16%-9.61M34.60%-1.67M43.29%-2.42M
Basic earnings per share 55.67%-4.1879.30%-7.0580.82%-40.0572.30%-8.143282.91%-8.183.88%-9.4357.57%-34.0564.20%-208.860.04%-29.477.03%-47.4
Diluted earnings per share 55.67%-4.1879.30%-7.0580.82%-40.0572.30%-8.143282.91%-8.183.88%-9.4357.57%-34.0564.20%-208.860.04%-29.477.03%-47.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg